Indian pharmaceutical vivimed poised to land in spain via purchase of two facilities in barcelona.
Business Investments
03 Oct 2011
Indian group vivimed has purchased industrial property in catalonia, with a view to expanding throughout europe, as it aims to become one of the world’s major suppliers of compounds to pharmaceutical companies. until now, it has centred on creation of compounds for dental hygiene products, sun creams and skin and hair care ranges.
in order to further its growth on the continent, the firm is tying up the takeover of uquifa, a major supplier of compounds to manufacturers of generic drugs produced by its two barcelona factories and another in mexico. the acquisition will provide the firm with a leg-up into the area of compounds which form the basis of medicaments that treat ulcers as well as anti-depressants. if the deals finally go through, there is every hope that the 390 employees on the payroll at uquifa will keep their jobs .
source: expansión, 21/9/2011
Related News and Success stories.
-
31 Jan 2025
US accelerator Braid Theory sets up European headquarters in Barcelona to boost blue economy
-
30 Jan 2025
Repsol to invest over €800M in the Tarragona Ecoplant, a pioneering project in Europe to produce renewable methanol
-
27 Jan 2025
Catalonia's Audiovisual industry grows 14% in one year, representing 3% of GDP with €8.636 billion in revenue
-
22 Jan 2025
Airbus GeoTech: How Catalonia’s innovation and talent drive Geospatial Data Excellence